Given the extensive evidence for bioenergetic failure in PD, elucidating the mechanism(s) of PGC−1α pathway dysfunction in PD patients may contribute additional insights into the etiopathogenesis of disease. This evidence concerns the gene PPARGC1A and Parkinson disease.